Cardiologists have moved to defend the use of the lipid lowering drug ezetimibe in certain patients after a post market review reveals that up to 15% of all patients on the drug could be receiving it outside of PBS restriction criteria. Regulators are now considering recommendations to remove all PBS restrictions on statins while moving ...
Cardiologists against moves to restrict ezetimibe prescribing
By Sunalie Silva
3 Feb 2017